Porter, Peggy L <br/><br/>
p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy.  [electronic resource] 

 -  Journal of the National Cancer Institute  Dec 2006 
 - 1723-31 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2105 
<br/><br/><label>Standard No.: </label>10.1093/jnci/djj467  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Chemotherapy, Adjuvant<br/>Cyclin E--genetics<br/>Cyclin-Dependent Kinase Inhibitor p27--genetics<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Doxorubicin--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Survival Analysis